0229 GMT April 21, 2021
The Health Ministry’s spokeswoman said at a press conference on Monday that 108 coronavirus patients died across the country from Sunday to Monday, bringing the total death toll to 60,181.
Sima Sadat Lari said the total number of people tested positive for COVID-19 infection in Iran exceeded 1,639,600 following the detection of 8,510 new cases during the same period, adding that 812 new cases have been admitted to the hospitals across the country, according to Tasnim News Agency.
Nearly 1.4 million patients have recovered from the coronavirus infection so far or have been discharged from hospitals across Iran, she added.
Among those undergoing treatment in medical centers at present, 3,727 coronavirus patients have critical health conditions because of more severe infection, said the spokeswoman.
Iran on Sunday announced bans on flights to and from 32 countries, including Britain and other states in Africa and Latin America, to stem the spread of the coronavirus.
Spokesman for the Civil Aviation Organization of Iran Mohammad Hassan Zibakhsh said that in line with the decisions made by the country’s National Headquarters for Managing and Fighting the Coronavirus, Iran will not accept passengers from high-risk countries in order to prevent the spread of the virus, Mehr News Agency reported.
The death toll has declined in Iran as movement restrictions in the country have been imposed since November, including inter-city travel bans, mask mandates and school closures.
Several provinces in the country have reported an increase in new positive cases, especially the southwestern province of Khuzestan, in which 11 cities are classified as “red” – the highest category in the country’s color-coded risk scale.
Iran’s vaccine drive recently has also gotten underway, with Russia’s Sputnik V vaccine administered to health workers this month. An additional 250,000 doses of the Chinese state-backed pharmaceutical Sinopharm, donated by Beijing, arrived in Iran in the early hours of Sunday.
Iranian scientists have already developed two coronavirus vaccines.
Iran’s CovIran Barekat, the country’s first domestically-developed COVID-19 vaccine, has shown 90-percent effectiveness, as confirmed by the first phase of human trials of the inoculation.
The second COVID-19 vaccine is a product of the Razi Vaccine and Serum Research Institute.